Clinical Trials and Drug Development
Rigorous clinical trials on Dementia drugs are continuing in USA and UK under the guidance of Alzheimer's society and it is reported that there is very less participation of people . The most of drugs are in second and third phases. Most of clinical trials are done in specific areas are amyloid beta plaques, the immune system, tau tangles . New medications for Dementia being developed in 2014/2015, 31% were named symptoms modifying. There are many developments are going on in Drug discovery of Dementia as old treatments are unable to stop the progression of Dementia. Most associations share their exploration on new medications for Dementia in Dementia conferences to get higher esteem to their items. This gets to be distinctly gainful to different geriatric doctors to redesign themselves with such medications and progressing possibilities by going to Dementia conferences. Such Dementia meetings will help researchers to know target areas for Drug development in Dementia and work towards it and also Dementia conferences exhibit clinical trial medications and offers positivity to discover new approaches in curing Dementia.
- Track 1-1 Development of Re-purposed Drugs
- Track 2-2 Beta-amyloid Polymerization and Inflammation Inhibitor
- Track 3-3 Prevention Trials
- Track 4-4 Anticonvulsant Drugs for Treatment
- Track 5-5 Vaccine Development against Beta-Amyloid
- Track 6-6 Animal Models for Toxicology Studies